Should we routinely supplement coronary patients with folate therapy to prevent in-stent restenosis?
Halabi
Abdul R
AR
Division of Cardiology, Duke University Medical Center, and the Duke Clinical Research Institute, Durham, NC 27715, USA. halab002@mc.duke.edu
Harrington
Robert A
RA
D003327:Coronary Disease / Q000150:complications* / Q000188:drug therapy*; D023903:Coronary Restenosis / Q000209:etiology* / Q000517:prevention & control*; D019317:Evidence-Based Medicine; D005492:Folic Acid / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D015607:Stents
D005492:Folic Acid